Live Breaking News & Updates on Kenneth Farber

Stay updated with breaking news from Kenneth farber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Two thirds of people with lupus would take COVID-19 vaccine, shows LRA survey


 E-Mail
New York, NY- December 16.  Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance (LRA). However, it is important to note that 24% say they would not take the vaccine while 22% are uncertain.
Conducted October 19 - November 17, the national survey included 703 people with lupus and 63 of their family members and friends. Respondents represented all 50 states, the District of Columbia, Puerto Rico and the Virgin Islands.
Those who would get the vaccine are just as motivated by wanting to protect others (97%) from the virus as they are about protecting themselves (98%). This finding is particularly poignant as the lupus population is considered more vulnerable to COVID-19 because their immune systems are weakened by the disease and many of its treatments. ....

New York , United States , Puerto Rico , District Of Columbia , Virgin Islands , Kenneth Farber , Kennethm Farber , Lupus Research Alliance , Pfizer Inc , Drug Administration , African American , Scientific Advisory Board , American Indian , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ப்வெர்டோ ரிக்கோ , மாவட்டம் ஆஃப் கொலம்பியா , கன்னி தீவுகள் , கெநெத் ஃபார்‌பர் , லூபஸ் ஆராய்ச்சி கூட்டணி , ஃபைசர் இன்க் , அமெரிக்கன் இந்தியன் ,

Two Out Of Three People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey


Share this article
Share this article
NEW YORK, Dec. 16, 2020 /PRNewswire/  Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance (LRA). However, it is important to note that 24% say they would not take the vaccine while 22% are uncertain.
Conducted October 19 - November 17, the national survey included 703 people with lupus and 63 of their family members and friends. Respondents represented all 50 states, the District of Columbia, Puerto Rico and the Virgin Islands.
Those who would get the vaccine are just as motivated by wanting to protect others (97%) from the virus as they are about protecting themselves (98%). This finding is particularly poignant as the lupus population is considered more vulnerable to COVID-19 because their immune systems are weakened by the disease and many of its treatments.   ....

Puerto Rico , United States , District Of Columbia , Virgin Islands , Kenneth Farber , Kennethm Farber , Lupus Research Alliance Board Of Directors , Lupus Research Alliance , Pfizer Inc , Drug Administration , African American , Scientific Advisory Board , American Indian , Lupus Research , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் , மாவட்டம் ஆஃப் கொலம்பியா , கன்னி தீவுகள் , கெநெத் ஃபார்‌பர் , லூபஸ் ஆராய்ச்சி கூட்டணி பலகை ஆஃப் இயக்குநர்கள் , லூபஸ் ஆராய்ச்சி கூட்டணி , ஃபைசர் இன்க் , அமெரிக்கன் இந்தியன் , லூபஸ் ஆராய்ச்சி ,